IC4: Pharmacology Flashcards

1
Q

What molecule synthesises neurotransmitters?

A

ChAT (choline acetyltransferase)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 2 receptors that neurotransmitters bind to?

A

GPCR (mAChR = muscarinic)
Ion channels (nAChR = nicotinic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the 2 receptors that neurotransmitters bind to?

A

GPCR (mAChR = muscarinic)
Ion channels (nAChR = nicotinic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the 4 main neurotransmitters found in the body and what kind of synapses are they usually involved in?

A

Glutamate - excitatory
GABA - inhibitory
Acetylcholine - learning, arousal and reward
Dopamine - motor systems and reward

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the 3 functions of the blood brain barrier?

A
  1. Modulation of the entry of metabolic substrates (especially glucose)
  2. Control of ion movement → Na-K-ATPase in barrier cells pump Na into the CSF and pumps K out into blood
  3. Prevention of access to CNS by toxins and peripheral neurotransmitters
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the non-saturable method of crossing the BBB and what characteristics make a drug a good candidate for this method?

A

Transmembrane passive diffusion

Drugs w LMW, high lipid solubility (not too high)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the saturable method of crossing the BBB and what are the 4 things that regulate it

A

Transporter systems

Regulated by cerebral blood flow, co-factors, hormones and efflux transporters (eg. P-glycoprotein)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe generalised seizures

A

involve the entire brain, will cause loss of consciousness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the 4 main types of generalised seizures?

A

Tonic clonic (Grand mal)
Absence (Petit mal)
Myoclonic
Atonic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the 2 types of partial seizures

A

Simple (consciousness not impaired)
Complex (impaired consciousness)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is phenytoin’s MOA

A

Blocks VG-Na+ channels, decreasing Na+ influx hence preventing the formation of an AP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Where can phenytoin be used

A

All but absence seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What must be taken note of for PHT monitoring

A

Narrow tp range, w saturation kinetics, non-linear relationship between dose and plasma concentration necessitating titration and monitoring

PHT is also teratogenic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is CBZ’s MOA

A

Blocks VG-Na+ channels, decreasing Na+ influx hence preventing the formation of an AP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Where can CBZ be used?

A

All but absence seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What enzymes are implicated with CBZ?

A

CYP450 inducer
Its own t-half decreases with repeated doses and increases elimination of other drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What must be screened for prior to CBZ use?

A

HLA-B*1502 (SJS/TEN risk)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is valproate’s MOA? (3)

A

Blocks VG-Na+ AND Ca2+ channels, decreasing Na+ influx hence preventing the formation of an AP

Also inhibits GABA transaminase (hence increasing GABA levels)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Where can valproate be used?

A

Suitable for ALL seizure types

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What should be taken note of for valproate?

A

Highly protein bound and will displace other ASMs

21
Q

What are the general dose-related SEs for ASMs? (6)

A

drowsiness, confusion, ataxia, slurred speech, mental changes, coma

22
Q

What are the general non-dose-related SEs for ASMs? (6)

A

hirsutism, acne, gingival hyperplasia, folate deficiency, osteomalacia, HS rxns

23
Q

How can ODs occur with benzodiazepines and what should be used to treat it?

A

Overdose and/or concurrent use with alcohol

Treat with flumazenil

24
Q

Why arent benzodiazepines and barbituates used as often?

A

High instances of tolerance and dependence

Barbituates have a worse profile than benzodiazepines

25
How do barbituates differ from benzodiazepines in terms of MOA?
Barbituates also potentiate GABA(A) mediated Cl- currents but at a site distinct from benzodiazepines (hence flumazenil does not work in cases of overdose)
26
What are the 3 other non-first line ASMs?
Levetiracetam Lamotrigene Topiramate
27
What is levetiracetam used for? (3)
Adjunctive therapy for: partial onset seizures myoclonic seizures primary generalised tonic-clonic seizures
28
What are some common and rare SE for levetiracetam? (3+3)
Common: HA, vertigo, insomnia Rare: agranulocytosis, suicide, delirium
29
What is lamotrigene's MOA?
Blocks VG-Na+ channels and inhibits glutamate release
30
What is lamotrigene indicated for? (3)
adjunctive or monotherapy treatment of: partial seizures generalised seizures (including absence) lennox-gastaut syndrome
31
What are some rare SEs of lamotrigene? (4)
agranulocytosis movement disorders (worsens Parkinson's) SJS/TEN hepatic failure
32
What is topiramate indicated for? (2 monotx, 1 adj)
monotherapy for: partial generalised seizures adjunctive therapy for: Lennox-Gastaut syndrome
33
Under which 3 circumstances should monitoring for ASMs be done?
1. assess compliance in pts w refractory epilepsy (but claim to be compliant) 2. assess sx due to ASM toxicity (especially w PHT) 3. to titrate PHT dose
34
Describe the general pathophysiology of a headache (4) VTNI
Vasodilation of intracranial extracerebral blood vessels → activation of the perivascular trigeminal nerves → release vasoactive neuropeptides → promote neurogenic inflammation
35
Which biological molecule has been implicated as an important mediator of migraines?
Serotonin (5-HT)
36
What is the general flow in migraine pharmacological management?
NSAIDs or paracetamol first If fail or in cases of moderate to severe migraines, try cafergot, sumatriptan or erenumab
37
What is cafergot and what is its MOA? (3)
caffeine + ergotamine tonic action on vascular smooth muscles in the external carotid network → stimulates α-adrenergic and 5-HT receptors → leading to vasoconstriction
38
When is cafergot indicated?
Acute tx of migraine, given at first sx of attack
39
What other drugs should cafergot not be given with? (2)
1. other CYP3A4 inhibitors (eg. macrolides) 2. other vasoconstrictors (ergot alkaloids, sumatriptan, other 5HT-1 agonists)
40
What are the two main severe SE to look out for with cafergot
MI and ergotism (vascular ischemia)
41
What is sumatriptan's MOA (2)
selective vascular serotonin (5-HT1d) receptor agonist → selectively constricts the carotid arterial circulation but does not alter cerebral blood flow → inhibits trigeminal blood flow
42
What is sumatriptan indicated for?
acute treatment of migraine with or without aura
43
What are the contraindications for taking sumatriptan? (3)
HS to triptans MI concurrent administration with MAOis
44
What is the main rare SE of sumatriptan?
minor disturbances in LFTs
45
What is CGRP?
Nociceptive neuropeptide at the trigeminal ganglion that acts as a vasodilator (more neuropeptide comes out, causes more pain)
46
What is erenumab's MOA (2)
Monoclonal antibody CGRP inhibitor blocks nociceptive perception (pain is decreased) alleviates vasodilation (less neuropeptide is released)
47
What is erenumab indicated for?
prophylaxis for migraine in adults who have at least 4 migraine days a month
48
How should erenumab be taken
SQ injection monthly, clinical benefit typically seen within 3 months